万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
http://joe.endocrinology-journals.org/
3、投稿网址：
https://mc.manuscriptcentral.com/sfe-joe
4、官网邮箱：joe@bioscientifica.com（编辑部）
5、期刊刊期：月刊，一年出版12期。
2021年7月31日星期六
投稿须知【官网信息】
Author guidelines
Editorial Process
Peer review
Submissions are assessed by the Editorial Board and are subject to external peer review using the single blind method whereby the authors are blinded to the identity of the reviewers and editors.
Due to the high volume of submissions received, the Editor-in-Chief and the Editorial Board operate a rapid triage system and only the top 34% of papers undergo full external peer review. This workflow is in place to allow authors to submit to a more appropriate journal with minimal delay.
On average the journal returns a decision on a peer-reviewed paper in 12 days.
Manuscript Transfer
If your paper is found to be outside the scope of Journal of Endocrinology you may be offered the opportunity to transfer it to Journal of Molecular Endocrinology or Endocrine Connections for rapid consideration. The offer to transfer is made at the discretion of the Editor-in-Chief, and may be made prior to or after full peer review. Authors may accept or decline the offer to transfer. If the offer is accepted after peer review, then the paper will be transferred along with the reviewer reports. This will assist the Editor-in-Chief of Journal of Molecular Endocrinology or Endocrine Connections to assess the suitability of the article for the journal, meaning that it may be possible for your paper to be accepted and published rapidly without further peer review, although acceptance is not guaranteed. All decisions made by an Editor-in-Chief of either journal are final.
Appeals
Authors who feel they have grounds to appeal a rejection decision should send a rebuttal letter to the editorial office, detailing the reasons for the appeal. Rebuttals will be considered by the Editor-in-Chief, often in consultation with the Editorial Board Member who handled the paper. Decisions on appeals are final.
Submission Checklist
Your article
Structure – Ensure the submission is structured as requested by the journal, and contains all relevant sections. See 'Preparation of Manuscripts' for further details.
Title page – All submissions must have a title page stating all of the relevant information. See 'General' for further details.
Format – All submissions should follow the journal guidelines for word count, page margins and line numbering. See 'General' for further details.
Language – Non-native English speakers are encouraged to have their manuscript professionally edited before submission. This is particular key for revised submissions. Click here for full details of our recommended English Language Editing Services.
Reported data – Data accuracy is crucial. Authors are strongly encouraged to double check all reported data for accuracy and to confirm that all units of measurement are correct and consistent.
References – Please see ‘References’ for full details of the journal’s required style.
Graphics – All figures and tables should be presented in a clear and informative manner with accompanying legends.
Ethical compliance – All articles are required to meet the requirements outlined in our ethical policy. Ensure you have included all relevant ethical approval statements.
Before submitting
Approval – Ensure all authors have seen and approved the final version of the article prior to submission. All authors must also approve the journal you are submitting to.
Open Access – The appropriate Open Access option must be selected on submission. Authors are responsible for ensuring any funder mandates are followed. For further details, please see the Open Access policy.
Charges – Journal of Endocrinology is committed to keeping costs to authors to a minimum, however some charges may apply. Authors are responsible for familiarising themselves with these prior to submission. Full details are available on our Publication charges page.
Uploading your submission
Author list – All authors must be listed on the title page and entered on the ScholarOne Manuscripts submission in the correct order. Ensure all author email addresses provided are valid. ORCID iDs can be added during the submission process, and will be displayed on the published article. Author information entered into ScholarOne Manuscripts will be used to generate PubMed listings for published papers.
Cover Letter – This letter should introduce your paper and outline why your work is important and suitable publication at this time.
File formats – Ensure all files are in the correct format for revised submissions. See ‘General’ for further instructions.
Figures and tables – Ensure all figures and table files are present and correct, and that they display clearly in the pdf proof.
Preparation of Manuscripts
General
Manuscripts should:
Be concise and clear.
Be limited to 5000 words for Research submissions. For information on other manuscript types please see the relevant section below.
Display the word count on the title page.
Contain no more than 10 figures and 60 references as recommended by the journal.
Use double line spacing throughout (including reference list and figure legends), and contain continuous line numbering down the left-side of each page.
Define all abbreviations when first mentioned.
Be submitted in the correct file type, ie. main document in an editable Word format.
Be written in either UK or US English.
Contain a title page.
Accepted file types:
Please be aware that the combined size of your files should not exceed 40 MB.
For article text: txt, doc, docx, rtf. We are unable to accept pdf files for article text for revised manuscripts but can do so for first submissions
For figures: eps, tiff, jpg, pdf
Changes within revised manuscripts should be highlighted using the highlighter function or coloured text, and should be accompanied by a full response letter to editor and reviewer comments.
Manuscript Categories
Research
All research submissions should be formatted in the following sections:
1. Title Page
Include a separate title page with:
Title (maximum 85 characters)
All authors names and full addresses
Corresponding author’s postal and email address
A short title (maximum 46 characters, including spaces)
A minimum of four keywords describing the manuscript
Word count of the full article, excluding references and figure legends
2. Abstract
The abstract should be a single paragraph of not more than 250 words, clearly stating the objective of the study or review, the methods used (where applicable), and summarizing results and conclusions. Avoid abbreviations and references in this section.
3. Introduction
The introduction should set the study in context by briefly reviewing relevant knowledge of the subject; follow this with a concise statement of the objectives of the study.
4. Materials and methods
Provide sufficient information for other workers to repeat the study. If well-established methods are used give a reference to the technique and provide full details of any modifications.
Include the source of chemicals, reagents and hormones and give the manufacturer’s name and location (town, country) in parentheses.
Give the generic name, dose and route of administration for drugs.
Specify the composition of buffers, solutions and culture media.
Use SI symbols, give concentrations in mol/L and define the term % as w/v or v/v for all solutions. For international units use IU (U should be used for enzyme activity).
Specify the type of equipment (microscopes/objective lenses, cameras, detectors) used to obtain images.
Specify any image acquisition software used, and give a description of specialized techniques requiring large amounts of processing, such as confocal, deconvolution, 3D reconstructions, or surface and volume rendering.
5. Results
The results should read as a narrative leading the reader through the experiments and investigations performed. Referencing and mention of others studies is permitted in the Results section where necessary or helpful.
6. Discussion
Should not simply re-state results, but should put them in the broader context and highlight the importance and novelty of the work.
7. Declaration of interest, Funding and Acknowledgements
Declaration of interest
Actual or perceived conflicts of interest for all authors must be declared in full.
Please either (a) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or (b) fully declare any financial or other potential conflict of interest.
Conflicts of interest include, but are not limited to:
Employment and consultancies
Grants, fees and honoraria
Ownership of stock or shares
Royalties
Patents (pending and actual)
Board membership
Funding
Please detail all of the sources of funding relevant to the research reported in the following format:
This work was supported by the Medical Research Council (grant numbers xxxx, yyyy); the Wellcome Trust (grant number xxxx); and Tommy’s Baby charity (grant number xxxx).
Where research has not been funded please state the following:
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author contribution statement (optional)
Please include a statement specifying the contribution of each co-author.
Acknowledgements
Please be as brief as possible.
8. References
All references cited in the text must be included in the reference list and vice versa. However, if a reference consists of only a web address do not include it in the reference list but cite it in the text, giving the date the page was accessed.
Unpublished work
Any unpublished work (personal communications, manuscripts in preparation and manuscripts submitted but not yet accepted for publication) must be referred to in the text and not listed in the references.
Give the full list of authors, including their initials. For example:
(A Stone, J Brown & M R Smith, unpublished observations)
(J Brown, personal communication)
Articles accepted for publication but not yet published may be listed as ‘in press’ in the reference list, using the current year as the publication year. If an ‘in press’ article is included in the Accepted Preprint service or a similar scheme, then the Digital Object Identifier (DOI) should be included; otherwise, provide a copy of the article as a supplementary file for reviewing purposes.
In the text
Cite references in the text using the authors’ names and publication year. Use et al. for articles with more than two authors. Where there are several citations, list them in chronological order.
In the reference list
List references in alphabetical order. Give articles by the same author in the order:
Single author
Two authors alphabetically according to the name of the second author
Three or more authors chronologically, with a, b and c etc. for articles published in the same year, in the order in which they are cited in the text
List a maximum of ten authors. Where there are more than ten authors, list the first ten and then use et al.
Reference in the following format:
See RH, Calvo D, Shi Y, Kawa H, Luke MP & Yuan Z 2001 Stimulation of p300-mediated transcription by the kinase MEKK1. Journal of Biological Chemistry 276 16310–16317.
Harvey SS 1975 Hypnotics and sedatives. The barbiturates. In The Pharmacological Basis of Therapeutics, edn 5, pp 102–123. Eds LS Goodman & A Gilman. New York: Macmillan Publishing Co.
EndNote
Please use Harvard style.
9. Statistical analysis
It is the author’s responsibility to document that the results are reproducible and that the differences found are not due to random variation. No absolute rules can be applied but, in general, quantitative data should be from no fewer than three replicate experiments. Appropriate statistical methods should be used to test the significance of differences in results. The term ‘significant’ should not be used unless statistical analysis was performed, and the probability value used to identify significance (eg P < 0.05) should be specified.
When several t-tests are employed, authors should be aware that nominal probability levels no longer apply. Accordingly, the multiple t-test, multiple range test or similar techniques to permit simultaneous comparisons should be employed. Also, in lieu of using several t-tests, it is often more appropriate to utilize an analysis of variance (ANOVA) to permit pooling of data, increase the number of degrees of freedom, and improve reliability of results. Authors should use appropriate nonparametric tests when the data depart substantially from a normal distribution.
In presenting results of linear regression analyses, it is desirable to show 95% confidence limits.
Bar charts are discouraged; spread plots or scatter plots more faithfully describe the data being presented. Please see the Editorial published within Reproduction for further guidance on this. When data points are fitted with lines, specify the method used for fitting (graphical, least squares, computer program). If differences in slopes and/or axis intercepts are claimed for plotted lines, these should be supported by statistical analysis.
Give sufficient details of the experimental design and analysis so that the reader can assess their adequacy and validity for testing the hypotheses of interest.
In particular:
Describe the numbers of experimental units used and the way in which they have been allocated to treatments
Outlier observations should not be removed from any analysis. Authors should justify the omission of any observations from the analysis if absolutely necessary
Describe methods of analysis precisely and state any necessary assumptions, as these may affect the conclusions that can be drawn from the experiment
Where possible authors are required to submit graphs with individual data points to directly show the spread of the data.
Your article may be sent to the Statistical Advisor for comments.
10. Tables
Tables should be concise. Tables too large for print publication should be submitted as supplementary data.
Number tables in the order they are cited in the text
Include a title – a single sentence at the head of the table that includes the name of the organism studied
Use footnotes to provide any additional explanatory material, cross-referenced to the column entries
Give a short heading for each column
Do not use internal horizontal or vertical lines, colour or shading
Explain all abbreviations used in the table in the footnotes
Please note that the option to print large tables in a final article is subject to editorial approval. If the tables are deemed too large for the final article, you will be asked to publish your tables as supplementary data and charges will apply.
11. Figures
The journal has produced digital image guidelines in order to clarify the standards expected by the journal. All submitted digital images must adhere to these guidelines.
Colour figures will be published online at no charge to the author. Publication of colour figures in the print version will incur a charge that must be paid before publication. Please note the option to print in greyscale is subject to editorial approval, if the meaning of your image is unclear you will be asked to print in colour and a charge will apply.
Number figures in the order they are cited in the text
Include legends to all figures, giving the figure number, keys to any symbols used, the name of the organism studied, the names of any statistical tests used and the probability levels used for comparisons
Label figure sections as A, B etc in the top left-hand corner
Use Arial or a similar sans-serif font for text labels
Do not enclose figures in boxes
Indicate magnification by a scale bar in the bottom right-hand corner of the image and give the measurement in the legend
Use the preferred symbols of closed and open circles, squares and triangles. Ensure that symbols are large enough to be read clearly when the figure is reduced for publication
Use Courier or a similar non-proportional font for amino acid, DNA, RNA and PCR primer sequences and highlight sections of homology between sequences with grey shading
……
更多详情：
https://joe.bioscientifica.com/page/author/author-guidelines
